These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31394990)

  • 21. Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
    Oskoui M; Pringsheim T; Billinghurst L; Potrebic S; Gersz EM; Gloss D; Holler-Managan Y; Leininger E; Licking N; Mack K; Powers SW; Sowell M; Cristina Victorio M; Yonker M; Zanitsch H; Hershey AD
    Headache; 2019 Sep; 59(8):1144-1157. PubMed ID: 31529477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persuasive Effects of Message Framing and Narrative Format on Promoting COVID-19 Vaccination: A Study on Chinese College Students.
    Ye W; Li Q; Yu S
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society.
    Oskoui M; Pringsheim T; Billinghurst L; Potrebic S; Gersz EM; Gloss D; Holler-Managan Y; Leininger E; Licking N; Mack K; Powers SW; Sowell M; Victorio MC; Yonker M; Zanitsch H; Hershey AD
    Neurology; 2019 Sep; 93(11):500-509. PubMed ID: 31413170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
    Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
    Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acupuncture for the prevention of episodic migraine.
    Linde K; Allais G; Brinkhaus B; Fei Y; Mehring M; Vertosick EA; Vickers A; White AR
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD001218. PubMed ID: 27351677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive Behavioral Therapy plus Amitriptyline for Children and Adolescents with Chronic Migraine Reduces Headache Days to ≤4 Per Month.
    Kroner JW; Hershey AD; Kashikar-Zuck SM; LeCates SL; Allen JR; Slater SK; Zafar M; Kabbouche MA; O'Brien HL; Shenk CE; Rausch JR; Kroon Van Diest AM; Powers SW
    Headache; 2016 Apr; 56(4):711-6. PubMed ID: 26992129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study.
    Kawata AK; Shah N; Poon JL; Shaffer S; Sapra S; Wilcox TK; Shah S; Tepper SJ; Dodick DW; Lipton RB
    Headache; 2021 Mar; 61(3):438-454. PubMed ID: 33594686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility assessment of telephone-administered behavioral treatment for adolescent migraine.
    Cottrell C; Drew J; Gibson J; Holroyd K; O'Donnell F
    Headache; 2007 Oct; 47(9):1293-302. PubMed ID: 17927645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.
    Mansfield C; Gebben DJ; Sutphin J; Tepper SJ; Schwedt TJ; Sapra S; Shah N
    Headache; 2019 May; 59(5):715-726. PubMed ID: 30861110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic versus episodic migraine: The 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency.
    Ishii R; Schwedt TJ; Dumkrieger G; Lalvani N; Craven A; Goadsby PJ; Lipton RB; Olesen J; Silberstein SD; Burish MJ; Dodick DW
    Headache; 2021 Jul; 61(7):992-1003. PubMed ID: 34081791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.
    Lipton RB; Manack Adams A; Buse DC; Fanning KM; Reed ML
    Headache; 2016 Sep; 56(8):1280-9. PubMed ID: 27349336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barriers to the diagnosis and treatment of migraine: effects of sex, income, and headache features.
    Lipton RB; Serrano D; Holland S; Fanning KM; Reed ML; Buse DC
    Headache; 2013 Jan; 53(1):81-92. PubMed ID: 23078241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reading or Listening to a Gain- or Loss-Framed Health Message: Effects of Message Framing and Communication Mode in the Context of Fruit and Vegetable Intake.
    Elbert SP; Ots P
    J Health Commun; 2018; 23(6):573-580. PubMed ID: 29985782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoting HPV Vaccination Online: Message Design and Media Choice.
    Lee MJ; Cho J
    Health Promot Pract; 2017 Sep; 18(5):645-653. PubMed ID: 28129691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical Trial.
    Skljarevski V; Oakes TM; Zhang Q; Ferguson MB; Martinez J; Camporeale A; Johnson KW; Shan Q; Carter J; Schacht A; Goadsby PJ; Dodick DW
    JAMA Neurol; 2018 Feb; 75(2):187-193. PubMed ID: 29255900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic treatment of pediatric migraine.
    Lewis DW; Diamond S; Scott D; Jones V
    Headache; 2004 Mar; 44(3):230-7. PubMed ID: 15012660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients' management of migraine and chronic daily headache: a study of the members of the Migraine Action Association (United Kingdom).
    Peters M; Abu-Saad HH; Robbins I; Vydelingum V; Dowson A; Murphy M
    Headache; 2005 May; 45(5):571-81. PubMed ID: 15953276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC; Loder EW; Gorman JA; Stewart WF; Reed ML; Fanning KM; Serrano D; Lipton RB
    Headache; 2013 Sep; 53(8):1278-99. PubMed ID: 23808666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cycling Through Migraine Preventive Treatments: Implications for All-Cause Total Direct Costs and Disease-Specific Costs.
    Ford JH; Schroeder K; Nyhuis AW; Foster SA; Aurora SK
    J Manag Care Spec Pharm; 2019 Jan; 25(1):46-59. PubMed ID: 30044691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging behavioral treatments for migraine.
    Smitherman TA; Wells RE; Ford SG
    Curr Pain Headache Rep; 2015 Apr; 19(4):13. PubMed ID: 25819975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.